Advertisement

Topics

ElevateBio launches with $150M Series A – to launch cell and gene therapy companies

13:32 EDT 13 May 2019 | MedCity News

The firm will follow a model similar to that of BridgeBio, partnering with scientific researchers and launching companies to develop and commercialize their products.

Original Article: ElevateBio launches with $150M Series A – to launch cell and gene therapy companies

NEXT ARTICLE

More From BioPortfolio on "ElevateBio launches with $150M Series A – to launch cell and gene therapy companies"

Advertisement
Quick Search
Advertisement
Advertisement